Literature DB >> 1445745

Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

L A Akslen1, A O Myking, H Salvesen, J E Varhaug.   

Abstract

The influence of various pathological features on tumour recurrences and cancer deaths has been studied in 173 consecutive cases of surgically treated papillary thyroid carcinoma recorded in 1971-1985. During the follow-up (median 7.3 years), 18.6% of the 161 radically treated patients had recurrent disease, and 8.7% died of thyroid cancer. In the univariate life-table analysis, recurrence-free survival was significantly related to age, pTNM category, tumour size, presence of certain growth patterns, tumour necrosis, tumour infiltration in surrounding thyroid tissue and thyroid gland capsule, lymph node metastases, presence of extra-nodal tumour growth and number of positive lymph nodes, whereas only tumour diameter, thyroid gland capsular infiltration and presence of extra-nodal tumour growth remained as significant prognostic factors in the multivariate analysis. Regarding thyroid cancer deaths, sex, age, pTNM category, radicality of surgical treatment, tumour diameter, macroscopic appearance, cellular atypia, tumour necrosis, thyroid gland capsular infiltration, vascular invasion, extra-thyroidal extension and lymph node metastases were all significant variables in the univariate analysis. However, only sex, age, radicality of surgical treatment and vascular invasion were found to be significant predictors of thyroid cancer deaths in the final multivariate Cox model, whereas cellular atypia and necrosis showed a borderline significance. Our study thus documents the independent importance of certain histological features for morbidity and mortality in surgically treated cases of papillary thyroid cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1445745     DOI: 10.1016/0959-8049(93)90574-y

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

1.  Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.

Authors:  Volkert B Wreesmann; Iain J Nixon; Michael Rivera; Nora Katabi; Frank Palmer; Ian Ganly; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ronald A Ghossein
Journal:  Thyroid       Date:  2015-03-31       Impact factor: 6.568

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma.

Authors:  Laura Falvo; Antonio Catania; Vito D'Andrea; Antonella Marzullo; Maria Cristina Giustiniani; Enrico De Antoni
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

4.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Association between prognostic factors and clinical outcome of well-differentiated thyroid carcinoma: A retrospective 10-year follow-up study.

Authors:  Shangtong Lei; Zihai Ding; Junna Ge; Donghui Zhao
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

6.  Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe.

Authors:  Yasuhiro Ito; Tomoo Jikuzono; Takuya Higashiyama; Shuji Asahi; Chisato Tomoda; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

7.  Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.

Authors:  Chung-Yau Lo; Wai-Fan Chan; King-Yin Lam; Koon-Yat Wan
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

8.  Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.

Authors:  Ekua Yorke; Adrienne Melck; Sam M Wiseman
Journal:  Can J Surg       Date:  2016-08       Impact factor: 2.089

9.  Parathyroid invasion, nodal recurrence, and lung metastasis by papillary carcinoma of the thyroid.

Authors:  K Kakudo; W Tang; Y Ito; Y Nakamura; H Yasuoka; S Morita; A Miyauchi
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

10.  Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.

Authors:  H Wanebo; M Coburn; D Teates; B Cole
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.